Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Papillomavirus and treatment.

Robert Snoeck1

  • 1Rega Institute for Medical Research, K.U. Leuven, Belgium. robert.snoeck@rega.kuleuven.ac.be

Antiviral Research
|July 13, 2006
PubMed
Summary

Human papillomaviruses (HPVs) cause epithelial cell proliferation, leading to benign and malignant lesions like cervical cancer. Research is advancing prophylactic vaccines and exploring treatments beyond surgery for HPV-related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of novel perillyl and myrtenyl nucleobase conjugates as dual anti-Alzheimer and antimicrobial agents.

Molecular diversity·2026
Same author

Membrane-Permeable Nucleoside T-1106 Diphosphate and Triphosphate Analogues as Antiviral Pronucleotides.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

2-Quinolone-1,2,3-triazole-benzofuran-N-acylhydrazone hybrids as antiviral and antimicrobial agents: synthesis, in vitro screening and molecular modeling.

Molecular diversity·2026
Same author

Emergence of Antiviral Drug Resistance in Congenital Cytomegalovirus Infection During Treatment: An Updated Review of Literature and Case Report.

The Pediatric infectious disease journal·2025
Same author

Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase.

Viruses·2025
Same author

Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient.

The Journal of antimicrobial chemotherapy·2025

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Human papillomaviruses (HPVs) are DNA viruses causing epithelial cell proliferation.
  • HPVs are linked to various benign and malignant lesions, notably cervical carcinoma.
  • Understanding HPV immunobiology has spurred the development of prophylactic vaccines.

Purpose of the Study:

  • To review current treatment modalities for HPV-induced lesions.
  • To highlight the limitations of existing surgical approaches.
  • To emphasize the need for novel adjuvant therapies.

Main Methods:

  • Literature review of HPV lesion treatments.
  • Analysis of surgical intervention effectiveness.
  • Discussion of immunobiological insights.

Main Results:

  • Current HPV lesion treatments predominantly rely on surgical methods.
  • Prophylactic vaccines targeting common genital HPV types are under evaluation.
  • Adjuvant therapies are crucial for comprehensive HPV lesion management.

Conclusions:

  • Surgery remains a primary treatment for HPV lesions.
  • Further development of adjuvant therapies is essential.
  • Advancements in understanding HPV immunobiology are key to improved treatments.

Related Experiment Videos